- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsed or Refractory Hematological Malignancies in United Kingdom
Total 4742 results
-
Effector TherapeuticsTerminated
-
Blueprint Medicines CorporationCompletedMast Cell Leukemia | Aggressive Systemic Mastocytosis | Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease | Relapsed or Refractory Myeloid MalignanciesUnited States, United Kingdom
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingRelapsed or Refractory Solid TumorsUnited States, Argentina, Australia, Belgium, Croatia, Czechia, France, Guatemala, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Peru, Russian Federation, Serbia, South Africa, Spain, Sweden, Turkey
-
Spectrum Health HospitalsMillennium Pharmaceuticals, Inc.CompletedHematological MalignancyUnited States
-
HutchmedRecruitingIsocitrate Dehydrogenase Gene MutationSpain, United States
-
PfizerCompletedSolid Tumor and Hematologic MalignanciesUnited States
-
Emory UniversityTerminatedThrombocytopenia | Hematological MalignanciesUnited States
-
Foghorn Therapeutics Inc.RecruitingRefractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Relapsed Acute Myeloid Leukemia | Relapsed Myelodysplastic Syndromes | Refractory Myelodysplastic Syndromes | Advanced Hematologic Malignancy | Relapsed Chronic Myelomonocytic LeukemiaUnited States
-
University of Michigan Rogel Cancer CenterOtsuka Pharmaceutical Development & Commercialization, Inc.Completed
-
Anthony Sung, MDMassachusetts General HospitalCompleted
-
Washington University School of MedicineRecruitingPediatric Hematologic MalignanciesUnited States
-
M.D. Anderson Cancer CenterImmunoGen, Inc.Completed
-
Accutar Biotechnology IncRecruitingRelapsed/Refractory B-cell MalignanciesUnited States
-
Aaron Cumpston, PharmD, BCOPCompletedNeutropenia | Hematological MalignancyUnited States
-
University of UtahTerminatedHigh Risk Hematologic MalignanciesUnited States
-
Oncternal Therapeutics, IncRecruitingRelapsed/Refractory Aggressive B-Cell MalignanciesUnited States
-
IncuronTerminatedHematological MalignanciesUnited States
-
Gemin XCompletedHematological MalignanciesUnited States, Canada
-
Clavis PharmaSyneos Health; Theradex; CardiaBase; Learn & ConfirmCompletedRelapsed/Refractory AMLUnited Kingdom, Spain
-
Northside Hospital, Inc.RecruitingTransplant-Related Hematologic MalignancyUnited States
-
Caribou Biosciences, Inc.Enrolling by invitationLymphoma | Lymphoma, Non-Hodgkin | B Cell Lymphoma | Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Hematologic Malignancy | Relapsed/Refractory Multiple Myeloma | Relapsed/Refractory Acute Myeloid Leukemia | Relapsed Non-Hodgkin Lymphoma | B-Cell Non-Hodgkin's LymphomaUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...CompletedHematologic MalignancyUnited States
-
Clavis PharmaCompletedAML | Hematologic MalignanciesUnited States, United Kingdom, France, Germany, Italy, Norway
-
Anand B. KarnadCompletedAdvanced B-cell Lymphoid MalignanciesUnited States
-
M.D. Anderson Cancer CenterICN PharmaceuticalsCompletedHematological MalignanciesUnited States
-
Karyopharm Therapeutics IncCompletedHematological MalignanciesUnited States, Denmark, Canada
-
CelgeneCompletedHematologic Malignancy | Malignant LymphomaUnited States, United Kingdom
-
Precision BioSciences, Inc.RecruitingHematologic Malignancy | CD19 Expressing MalignanciesUnited States
-
CelgeneCompletedHematologic Malignancy | Malignant LymphomaUnited States, United Kingdom
-
Janssen Research & Development, LLCApproved for marketingRelapsed or Refractory Multiple MyelomaBrazil, Germany, Italy, Netherlands, Romania, Switzerland, United Kingdom
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Malignancies | Hematologic MalignanciesUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCancer and Aging Research GroupRecruitingLymphoma | Leukemia | MyelomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...RecruitingRefractory and/or Relapsed Metastatic Solid TumorsUnited States
-
Barbara Ann Karmanos Cancer InstituteCompletedHematological MalignanciesUnited States
-
University of ChicagoCompletedLeukemia | Preleukemia | Advanced Hematologic MalignanciesUnited States
-
Hangzhou Sumgen Biotech Co., Ltd.RecruitingSG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma.Lymphoma | Hematological MalignancyUnited States
-
St. Jude Children's Research HospitalAssisi Foundation; The Hartwell FoundationCompletedHematologic Malignancies | Disorder Related to Transplantation | Hematopoietic MalignancyUnited States
-
Cancer Research UKCompleted
-
St. Jude Children's Research HospitalRecruitingHematologic Malignancy | Myeloid MalignancyUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Novartis... and other collaboratorsTerminated
-
ExCellThera inc.Fred Hutchinson Cancer CenterActive, not recruitingHigh Risk Hematological Malignancy | Cord Blood TransplantUnited States, Netherlands
-
Acrotech Biopharma Inc.Axis Clinicals LimitedCompletedRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaUnited States
-
University of LeedsCompletedRelapsed or Refractory Multiple MyelomaUnited Kingdom
-
Baptist Health South FloridaWithdrawnNon-Hodgkin Lymphoma | Hematologic Malignancy | B-Cell Lymphoid MalignanciesUnited States
-
Memorial Sloan Kettering Cancer CenterJuno Therapeutics, Inc.Active, not recruitingChronic Lymphocytic Leukemia (CLL) | Refractory | RelapsedUnited States
-
Stichting Hemato-Oncologie voor Volwassenen NederlandCompletedMyelodysplastic Syndromes | LeukemiaUnited Kingdom
-
AstraZenecaCompletedAcute Myeloid Leukemia | Multiple Myeloma | Chronic Myelomonocytic Leukemia | Chronic Lymphocytic Leukemia | Acute Lymphocytic Leukemia | High Risk Myelodysplastic Syndrome | Small Lymphocytic Lymphoma | B-cell Non-Hodgkin Lymphoma | Richter's Syndrome | T-cell Non-Hodgkin Lymphoma | Relapsed or Refractory...United Kingdom, Germany, Netherlands
-
Sequana Medical N.V.CompletedRefractory or Recurrent AscitesSpain, United Kingdom, Italy, France, Austria
-
HutchmedCompleted
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of BirminghamRecruitingGlioma | Melanoma | Neoplasms by Histologic Type | Lymphoproliferative Disorders | Neoplasms by Site | Cancer | Brain Neoplasms | Solid Tumor | Malignant Neoplasm | Malignancy | Haematological MalignancyUnited Kingdom